-
艾媒咨询|2023年“董宇辉小作文事件”舆情监测分析报告
近日,“董宇辉小作文事件”相关话题热度不断,引发了大众对公司管理、企业文化和个人价值等方面的质疑和讨论,对此,本报告对“董宇辉小作文事件”进行了舆情监测分析。iiMedia Research(艾媒咨询)数据显示,有关“董宇辉小作文事件”的话题讨论热度自12月11日开始不断上升,整体网络口碑偏向负面,社会大众对事件的看法各异,网友态度呈负面转向。同时,效率、价格与情感是消费者进行直播间购物的重要考量点,直播行业在精神和物质层面对社会具有双重影响。
Recently, the topic of "Dong Yuhui's small essay incident" has been heated up, triggering questions and discussions about the company's management, corporate culture, and personal values, etc. Therewith, this report monitors and analyses the public opinion on "Dong Yuhui's small essay incident". According to iiMedia Research, the topic of "Dong Yuhui's small essay incident" has been rising since December 11, and the overall Internet word-of-mouth is on the negative side, with the general public having different views on the incident, and netizens' attitudes taking a negative turn. At the same time, efficiency, price and emotion are the most important considerations for consumers to make purchases in live broadcasting, and the live broadcasting industry has a dual impact on society in both spiritual and material aspects. -
艾媒报告|2019年12月-2020年1月中国医疗器械行业运行及上市公司双月度报告
本报告研究涉及企业/品牌包括:Mavidon,Titan Medical,Aspire Capital Fund,CentriMag,汇桥资本集团,联影医疗技术集团,医达极星,大博医疗,安捷伦,润扬医疗器械,迈瑞医疗,乐普医疗,威高医用,华大基因,安图生物,健帆生物,鱼跃医疗,京东方科技,美亚光电,东软集团,祥生医疗,硕世生物,佰仁医疗,爱博诺德,伟思医疗,安必平,林华医疗,拱东医疗,天智航,三友医疗,赛科希德等。
截至 2020 年 1 月 31 日 24:00,国家卫生健康委员会公布全国确诊病例 11791 例,重症病例 1795 例。短期来看,预计疫情将继续持续一段时间。肺炎疫情期间,病毒检测带动试剂盒需求增加;病毒治疗带动医用设备及医用耗材需求增加。部分医疗器械企业有望构成业绩增厚。
As of 24:00 on January 31, 2020, the National Health Commission announced 11791 confirmed cases and 1795 severe cases. In the short term, the outbreak is expected to continue for some time. During the pneumonia epidemic, virus detection drives demand for kits; virus treatment drives demand for medical equipment and supplies. Some medical device companies are expected to increase their performance. -
艾媒研报 |中国5G产业及5G概念股研究报告
5G作为中国的重点发展战略,预计到2025年中国5G资本支出将达到1.5万亿元(约合2230亿美元),有望带动国家直接经济产出6.3万亿元。总体而言,5G产业链由规划设计、基础设施建设、网络运营、产品及终端应用四大环节组成,无线主设备及传输设备这两部分占据通信网络产业链的大部分价值量。5G概念重要代表企业有中兴通讯(000063.SZ)、亨通光电(600487.SH)等。
China's 5G construction is in the leading position in the world. In the distribution of 5G industrial chain, wireless main equipment and transmission equipment occupy most of the value of the industrial chain. However, the threshold of network planning and design is high, and private design institutes need to be upgraded. In terms of wireless main equipment, antennas and PCBs are rising in volume and price, and the demand for small base stations is exploding. At the same time, 5G construction will continue to benefit transmission network equipment. -
艾媒报告|2019-2025全球5G产业发展趋势与商业应用模式研究报告
本报告研究涉及企业/品牌/案例:华为,电信,国脉科技,杰赛科技,恒泰实达,吉大通信,通宇通讯,京信通信,摩比发展(港股),东山精密,盛路通信,飞荣达,摩比发展(港股),东山精密,盛路通信,飞荣达,光迅科技,中际旭创,新易盛,天孚通信,剑桥科技,中兴通讯,诺基亚(美股),爱立信(美股),海格通信,宜通世纪,中富通,超讯通信,中通国脉,吉大通信,纵横通信
全球主要经济体加速推进5G商用落地,目前中国5G产业已形成规划、建设、运营和应用四大产业链环节,产业发展前景广阔,预计2025年中国5G连接数将达4.28亿个,带动直接经济产出达3.3万亿元。iiMedia Research(艾媒咨询)监测发现,2018年中国5G产业链各个环节相关企业营收均超亿元,发展态势良好。调查显示,有73.0%的网民看好5G技术未来发展,智能制造、车辆网、无线医疗是网民关注热点领域。而资本市场也积极关注5G产业生态圈,随着5G融入多项技术的程度加深,未来5G在传统行业的创新应用将成为重要的经济增长点,智慧出行、智慧医疗等下游应用率先成投资热点。
Major global economies have accelerated the promotion of 5G commercial landing. At present, China's 5G industry has formed four major industrial chains: planning, construction, operation and application. The industry has broad prospects for development. It is estimated that the number of 5G links in China will reach 428 million in 2025, and the direct economic output will reach 3.3 trillion yuan. IiMedia Research (Ai Media Consulting) monitoring found that in 2018, China's 5G industry chain in all aspects of the relevant enterprises revenue exceeded 100 million yuan, the development trend is good. According to the survey, 73.0% of the netizens are optimistic about the future development of 5G technology. Intelligent manufacturing, vehicle network and wireless medical treatment are the hotspots of netizens'attention. The capital market also pays close attention to the 5G industrial ecosphere. With the deepening integration of 5G into many technologies, the innovative application of 5G in traditional industries will become an important economic growth point in the future, and downstream applications such as smart travel and smart medical treatment will be the first investment hotspot. -
艾媒研报|科创板:2019年科创板受理企业及影子股分析研究报告
本报告研究涉及企业/品牌包括:科前生物、安翰科技、和舰芯片、容百科技、利元亨、江苏北人、天奈科技、睿创微纳、晶晨股份、贝斯达、华兴源创、微芯生物、特宝生物、国盾量子、虹软科技、世纪空间、光峰科技、福光股份、鸿泉物联、木瓜移动、优刻得、博众精工、创鑫激光、聚辰股份、海尔生物、天准科技、晶丰明源、申联生物、南微医学、美迪西、紫晶存储、苑东生物、恒安嘉新、乐鑫科技、龙软科技、杰普特、热景生物、瀚川智能、威胜信息、安博通、铂力特、视联动力、博瑞医药
2019年3月份科创板受理的企业包括:科前生物、安翰科技、和舰芯片、容百科技、利元亨、江苏北人、天奈科技、睿创微纳、晶晨股份、贝斯达、华兴源创、微芯生物、特宝生物、国盾量子、虹软科技、世纪空间、光峰科技、福光股份、鸿泉物联、木瓜移动等 2019年4月份受理的企业包括:优刻得、博众精工、创鑫激光、聚辰股份、海尔生物、天准科技、晶丰明源、申联生物、南微医学、美迪西、紫晶存储、苑东生物、恒安嘉新、乐鑫科技、龙软科技、杰普特、热景生物、瀚川智能、威胜信息、安博通、铂力特、视联动力、博瑞医药等,相应的重点影子股包括: TCL集团、华域汽车、天风证券、通化东宝、千方科技等。
In March and April 2019, the science and technology innovation board accepted the following enterprises: Wuhan Keqian Biology Co,Ltd, Ankon Technologies Co. Ltd, Hejian Technology (Suzhou) Co, Ltd, Ningbo Ronbay New Energy Technology Co, Ltd, Guangdong Lyric Robot Automation Co, Ltd, Jiangsu Beiren Robot System Co,Ltd, Jiangsu Cnano Technology Co, Ltd,Raytron Technology Co,Ltd,Amlogic (Shanghai) Co,Ltd, Shenzhen Basda Medical Apparatus Co,Ltd,Suzhou Hyc Technology Co,Ltd , etc. In April 2019, the science and technology innovation board accepted the following enterprises: Montage Technology Co, Ltd, UCloud Technology Co, Ltd, Bozhon Precision Industry Technology Co,Ltd, Shanghai Shen Lian Biomedical Corporation, Shanghai Bright Power Semiconductor Co, Ltd, Suzhou Tztek Technology Co,Ltd, Giantec Semiconductor Corporation, QINGDAO HAIER BIOMEDICAL CO, LTD. , MAXPHOTONICS Co, Ltd, Amethystum Storage Technology Co,Ltd , etc. -
艾媒报告 |2019年中国柔性显示产业研究与商业投资决策分析报告
本报告研究涉及企业/品牌包括:三星、iPhone、华为、小米、OPPO、京东方、深天马A、TCL集团、微信诺、华星光电、信利国际、和辉光电、柔宇科技、中能源、湖南群显、联得装备、同兴达、志云股份、国风塑业、新纶科技、时代新材、鼎龙股份、激智科技、晶华新材、万润股份、强力新材、东旭光电、莱宝高科、长信科技、ST康得新、中颖电子、士兰微、凯盛科技、康达新材、西部材料、传艺科技、金明精机、光莆股份、样子想你才、神宇股份、海顺新材、茂硕电源
政策支持和技术进步共同推动中国柔性显示产业快速发展。iiMedia Research(艾媒咨询)监测发现,2018年中国柔性显示游产业链各个环节相关企业营收均超亿元,相关上市公司中京东方A(000725.SZ)的网络关注度最高,隆华科技(300263.SZ)的网络口碑最好。但由于技术门槛高等相关因素影响,中国柔性显示产业上游发展基础薄弱,产业存在发展不成熟、技术欠缺和市场份额不足等问题。
The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry.
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告